In addition, it has been demonstrated that markers associated with CD8 + T cells exhibit great potential for advancing immunotherapy and predicting prognosis in multiple cancers.[22,23] Whereas few reports have revealed the effect of CD8 + T cells in SCLC to our knowledge. Here, CD8A is linked to small cell lung carcinoma.